[Hepatic and biliary repercussions of estrogens: dose or duration of treatment effect].
Hecht
Y
Y
D001660:Biliary Tract Diseases; D001695:Biology; D002779:Cholestasis; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003278:Contraceptives, Oral, Hormonal; D003710:Demography; D019049:Developed Countries; D004194:Disease; D004703:Endocrine System; D004967:Estrogens; D005060:Europe; D005193:Family Planning Services; D005602:France; D006728:Hormones; D008099:Liver; D008113:Liver Neoplasms; D009369:Neoplasms; D010827:Physiology; D011153:Population; D011157:Population Dynamics; D013812:Therapeutics; D013997:Time Factors
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003278:Contraceptives, Oral, Hormonal; D004967:Estrogens; D006728:Hormones
Biliary Tract Diseases--etiology; Biology; Cholestasis--etiology; Contraception; Contraceptive Agents, Estrogen--administraction and dosage; Contraceptive Agents, Female--administraction and dosage; Contraceptive Agents--administraction and dosage; Demographic Factors; Developed Countries; Diseases; Endocrine System; Estrogens--therapeutic use; Europe; Family Planning; France; Hepatic Effects--etiology; Hormones; Liver Neoplasms--etiology; Mediterranean Countries; Neoplasms; Physiology; Population; Population Dynamics; Time Factors; Treatment; Western Europe